Free Trial
→ Generate up to $5,000/month with 10X less money? (From Investors Alley) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
EKG
First Trust Nasdaq Lux Digital Health Solutions ETF
$17.58
+0.8%		$17.40
$13.87
▼
$18.84
$3.53M1.591,429 shs149 shs
EWEB
Global X Emerging Markets Internet & E-commerce ETF
$21.14
$21.14
$18.42
▼
$25.54
$2.54M0.42469 shsN/A
NZUS
SPDR MSCI USA Climate Paris Aligned ETF
$33.90
-0.4%		$33.48
$26.06
▼
$34.29
$2.71M-1.1622 shs243 shs
Kelly CRISPR & Gene Editing Technology ETF stock logo
XDNA
Kelly CRISPR & Gene Editing Technology ETF
$7.38
$7.38
$5.87
▼
$11.83
$2.21M0.923,034 shsN/A
The 10 Best AI Stocks to Own in 2025 Cover
The 10 Best AI Stocks to Own in 2025

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
EKG
First Trust Nasdaq Lux Digital Health Solutions ETF
+2.16%+1.27%+5.88%-0.02%+6.78%
EWEB
Global X Emerging Markets Internet & E-commerce ETF
0.00%0.00%0.00%0.00%0.00%
NZUS
SPDR MSCI USA Climate Paris Aligned ETF
-0.22%-0.69%+1.25%+6.19%+9.12%
Kelly CRISPR & Gene Editing Technology ETF stock logo
XDNA
Kelly CRISPR & Gene Editing Technology ETF
0.00%0.00%0.00%0.00%0.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
EKG
First Trust Nasdaq Lux Digital Health Solutions ETF
$17.58
+0.8%		$17.40
$13.87
▼
$18.84
$3.53M1.591,429 shs149 shs
EWEB
Global X Emerging Markets Internet & E-commerce ETF
$21.14
$21.14
$18.42
▼
$25.54
$2.54M0.42469 shsN/A
NZUS
SPDR MSCI USA Climate Paris Aligned ETF
$33.90
-0.4%		$33.48
$26.06
▼
$34.29
$2.71M-1.1622 shs243 shs
Kelly CRISPR & Gene Editing Technology ETF stock logo
XDNA
Kelly CRISPR & Gene Editing Technology ETF
$7.38
$7.38
$5.87
▼
$11.83
$2.21M0.923,034 shsN/A
The 10 Best AI Stocks to Own in 2025 Cover
The 10 Best AI Stocks to Own in 2025

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
EKG
First Trust Nasdaq Lux Digital Health Solutions ETF
+2.16%+1.27%+5.88%-0.02%+6.78%
EWEB
Global X Emerging Markets Internet & E-commerce ETF
0.00%0.00%0.00%0.00%0.00%
NZUS
SPDR MSCI USA Climate Paris Aligned ETF
-0.22%-0.69%+1.25%+6.19%+9.12%
Kelly CRISPR & Gene Editing Technology ETF stock logo
XDNA
Kelly CRISPR & Gene Editing Technology ETF
0.00%0.00%0.00%0.00%0.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
EKG
First Trust Nasdaq Lux Digital Health Solutions ETF
2.66
Moderate Buy$17.58N/A
EWEB
Global X Emerging Markets Internet & E-commerce ETF
2.75
Moderate Buy$21.14N/A
NZUS
SPDR MSCI USA Climate Paris Aligned ETF
2.79
Moderate Buy$33.90N/A
Kelly CRISPR & Gene Editing Technology ETF stock logo
XDNA
Kelly CRISPR & Gene Editing Technology ETF
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
EKG
First Trust Nasdaq Lux Digital Health Solutions ETF
N/AN/AN/AN/AN/AN/A
EWEB
Global X Emerging Markets Internet & E-commerce ETF
N/AN/AN/AN/AN/AN/A
NZUS
SPDR MSCI USA Climate Paris Aligned ETF
N/AN/AN/AN/AN/AN/A
Kelly CRISPR & Gene Editing Technology ETF stock logo
XDNA
Kelly CRISPR & Gene Editing Technology ETF
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
EKG
First Trust Nasdaq Lux Digital Health Solutions ETF
N/AN/A38.88∞N/AN/AN/AN/AN/A
EWEB
Global X Emerging Markets Internet & E-commerce ETF
N/AN/A25.72∞N/AN/AN/AN/AN/A
NZUS
SPDR MSCI USA Climate Paris Aligned ETF
N/AN/A31.50∞N/AN/AN/AN/AN/A
Kelly CRISPR & Gene Editing Technology ETF stock logo
XDNA
Kelly CRISPR & Gene Editing Technology ETF
N/AN/A17.02∞N/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
EKG
First Trust Nasdaq Lux Digital Health Solutions ETF
N/AN/AN/AN/AN/A
EWEB
Global X Emerging Markets Internet & E-commerce ETF
$0.060.28%N/AN/AN/A
NZUS
SPDR MSCI USA Climate Paris Aligned ETF
$1.795.28%N/AN/AN/A
Kelly CRISPR & Gene Editing Technology ETF stock logo
XDNA
Kelly CRISPR & Gene Editing Technology ETF
N/A0.12%N/AN/AN/A

Latest EWEB, XDNA, EKG, and NZUS Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
8/29/2025
NZUS
SPDR MSCI USA Climate Paris Aligned ETF
quarterly$0.07650.92%9/2/20259/2/20259/4/2025
(Data available from 1/1/2013 forward)

Institutional Ownership

CompanyInstitutional Ownership
EKG
First Trust Nasdaq Lux Digital Health Solutions ETF
N/A
EWEB
Global X Emerging Markets Internet & E-commerce ETF
N/A
NZUS
SPDR MSCI USA Climate Paris Aligned ETF
N/A
Kelly CRISPR & Gene Editing Technology ETF stock logo
XDNA
Kelly CRISPR & Gene Editing Technology ETF
N/A

Insider Ownership

CompanyInsider Ownership
EKG
First Trust Nasdaq Lux Digital Health Solutions ETF
N/A
EWEB
Global X Emerging Markets Internet & E-commerce ETF
N/A
NZUS
SPDR MSCI USA Climate Paris Aligned ETF
N/A
Kelly CRISPR & Gene Editing Technology ETF stock logo
XDNA
Kelly CRISPR & Gene Editing Technology ETF
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
EKG
First Trust Nasdaq Lux Digital Health Solutions ETF
N/A200,000N/AOptionable
EWEB
Global X Emerging Markets Internet & E-commerce ETF
N/A120,000N/ANo Data
NZUS
SPDR MSCI USA Climate Paris Aligned ETF
N/A80,000N/AOptionable
Kelly CRISPR & Gene Editing Technology ETF stock logo
XDNA
Kelly CRISPR & Gene Editing Technology ETF
N/A300,000N/AOptionable

Recent News About These Companies

Investment Guide to Genetics Stocks and ETFs
August 28, 2025  |  nai500.comN
CHOP, Penn advance CRISPR gene editing with fast-developed treatment for an infant with a rare disease
May 15, 2025  |  msn.comhttps://www.msn.com/en-us/science/biology/chop-penn-advance-crispr-gene-editing-with-fast-developed-treatment-for-an-infant-with-a-rare-disease/ar-AA1EQMQr
Nobel Prize winners convince court to revive CRISPR patent dispute
May 12, 2025  |  reuters.comhttps://www.reuters.com/legal/government/nobel-prize-winners-convince-court-revive-crispr-patent-dispute-2025-05-12/
Biotech investors: Stop expecting CRISPR science to make big leaps
April 14, 2025  |  statnews.comS
AI and gene editing promise ‘bespoke proteins’ for biotech
October 8, 2024  |  siliconrepublic.comS
Weight loss drug breakthroughs, gene therapies, and more: 8 clinical trials to watch right now
October 2, 2024  |  yahoo.comhttps://www.yahoo.com/tech/weight-loss-drug-breakthroughs-gene-090000589.html
K-12 Genome Editing at Only $2 a Pop
September 27, 2024  |  yahoo.comhttps://www.yahoo.com/tech/k-12-genome-editing-only-144035108.html
Vertex Stock: Came For CF Drugs, Staying For Gene Therapy
August 2, 2024  |  seekingalpha.comhttps://seekingalpha.com/article/4709620-vertex-stock-came-for-cf-drugs-staying-for-gene-therapy
CRISPR can treat common form of inherited blindness, early data hint
May 15, 2024  |  msn.comhttps://www.msn.com/en-gb/health/other/crispr-can-treat-common-form-of-inherited-blindness-early-data-hint/ar-BB1mrQQG
CRISPR gene editing: in summary
March 27, 2024  |  biotechniques.comB
CRISPR Technology Takes Center Stage at SXSW 2024 for the First Time
March 8, 2024  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/crispr-technology-takes-center-stage-at-sxsw-2024-for-the-first-time-1033147575
Intellia Collaborates With ReCode To Develop Gene Therapy For Cystic Fibrosis
February 15, 2024  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/intellia-collaborates-with-recode-to-develop-gene-therapy-for-cystic-fibrosis-1033071688
CRISPR Technology: Unveiling the Breakthrough in Gene Editing and Its Far-Reaching Implications
January 18, 2024  |  techbullion.comT
Here's Why CRISPR Therapeutics Stock Rose 54% Last Year
January 15, 2024  |  msn.comhttps://www.msn.com/en-us/money/other/here-s-why-crispr-therapeutics-stock-rose-54-last-year/ar-AA1n1jau
Gene editing is now a medical reality
December 8, 2023  |  news.yahoo.comhttps://news.yahoo.com/gene-editing-now-medical-reality-224326223.html
FDA approves first use of CRISPR gene editing to treat sickle cell disease
December 8, 2023  |  news.yahoo.comhttps://news.yahoo.com/fda-approves-first-crispr-gene-173254689.html
FDA Approves First Gene-Editing Cell Therapy For Sickle Cell Disease, An Inherited Blood Disorder
December 8, 2023  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/fda-approves-first-gene-editing-cell-therapy-for-sickle-cell-disease-an-inherited-blood-disorder-1032886628
Gene Editing Will Change Medicine—and Maybe Health Investing Too
November 24, 2023  |  msn.comhttps://www.msn.com/en-us/health/other/gene-editing-will-change-medicine-and-maybe-health-investing-too/ar-AA1ksQev
CRISPR/Cas9 unlocks TuMV resistance in Chinese cabbage: A leap forward in genome-edited plant breeding
November 23, 2023  |  phys.orgP
Is CRISPR Therapeutics the Best Gene-Editing Stock?
November 22, 2023  |  msn.comhttps://www.msn.com/en-us/money/other/is-crispr-therapeutics-the-best-gene-editing-stock/ar-AA1klNrx

Media Sentiment Over Time

First Trust Nasdaq Lux Digital Health Solutions ETF NASDAQ:EKG

$17.58 +0.15 (+0.84%)
As of 09/5/2025 02:10 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

The First Trust Nasdaq Lux Digital Health Solutions ETF (EKG) is an exchange-traded fund that is based on the NASDAQ Lux Health Tech index. The fund tracks a market cap-weighted index of globally-listed companies engaged in digital health technologies. EKG was launched on Mar 22, 2022 and is managed by First Trust.

Global X Emerging Markets Internet & E-commerce ETF NASDAQ:EWEB

$21.14 0.00 (0.00%)
As of 09/5/2025

The Global X Emerging Markets Internet & E-commerce ETF (EWEB) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks an index of companies positioned to benefit from the advancement of internet and e-commerce technologies in emerging market countries. EWEB was launched on Nov 9, 2020 and is managed by Global X.

SPDR MSCI USA Climate Paris Aligned ETF NASDAQ:NZUS

$33.90 -0.14 (-0.40%)
Closing price 09/5/2025 02:23 PM Eastern
Extended Trading
$33.90 0.00 (0.00%)
As of 09/5/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

The SPDR MSCI USA Climate Paris Aligned ETF (NZUS) is an exchange-traded fund that is based on the MSCI USA Climate Paris Aligned index. The fund tracks a tier-weighted index of large- and mid-cap US stocks selected and weighted based on ESG criteria that are compatible with the Paris Climate Agreement and carbon reduction goals. NZUS was launched on Apr 21, 2022 and is managed by State Street.

Kelly CRISPR & Gene Editing Technology ETF stock logo

Kelly CRISPR & Gene Editing Technology ETF NASDAQ:XDNA

$7.38 0.00 (0.00%)
As of 09/5/2025

The Strategic CRISPR & Gene Editing Technology ETF (XDNA) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market-cap-weighted index of companies in developed markets that focus on the advancements in DNA modification technology. XDNA was launched on Jan 12, 2022 and is managed by Kelly.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas